News

12:56

TSX Venture Exchange Cease Trade Order (CNW Group)

11:34

Dotcom Cash: Workout Online (FOX Business Now)

http://us.news2.yimg.com/us.yimg.com/p/fi/27/98/10.jpg/yfinance/fbc/marketupdate/Customers_use_the_Web_for_personal_training_g4094http://www.foxbusiness.com/http://us.js2.yimg.com/us.js.yimg.com/i/us/fi/pf/images/200711131752/providers/fp_fox_gold.png

Source: CARDIOME PHARMA CORP

11:34

Oncolytics Biotech(R) Inc. Announces 2009 Year End Results (CNW Group)

Source: ONCOLYTICS BIOTECH INC

11:34

Ambrilia Biopharma Provides Bi-Weekly Update on its Status and Restructuring Efforts (Marketwire)

Source: AMBRILIA BIOPHARMA INC.

11:34

TSX Venture Exchange Cease Trade Order (CNW Group)

Source: TOXIN ALERT INC.

23:13

New studies show DiagnoCure's PCA3 prostate cancer marker can help guide repeat prostate biopsy decisions and predict risk of aggressive cancer (CNW Group)

Source: DIAGNOCURE INC

23:13

Ambrilia Biopharma Provides Bi-Weekly Update on its Status and Restructuring Efforts (Marketwire)

Source: AMBRILIA BIOPHARMA INC.

21:53

CANADA STOCKS-TSX may open higher on resources, Schlumberger

Source: LABOPHARM INC

21:53

Patheon Announces Date of First Quarter 2010 Financial Results and Conference Call (CNW Group)

Source: PATHEON INCORPORATED

19:35

Cardiome to Release Fourth Quarter and Fiscal 2009 Results (CNW Group)

Cardiome Pharma Corp. today announced that it will report financial results for the fourth quarter and fiscal year ended December 31, 2009 on the afternoon of Tuesday, March 9, 2010.

Source: CARDIOME PHARMA CORP

19:35

YM BioSciences increases offering size to approximately US$17.5 million (CNW Group)

Source: YM BIOSCIENCES INC

19:35

Patheon Announces Date of First Quarter 2010 Financial Results and Conference Call (CNW Group)

Source: PATHEON INCORPORATED

07:52

YM BioSciences increases offering size to approximately US$17.5 million (CNW Group)

Source: YM BIOSCIENCES INC

06:14

New studies show DiagnoCure's PCA3 prostate cancer marker can help guide repeat prostate biopsy decisions and predict risk of aggressive cancer (CNW Group)

Source: DIAGNOCURE INC

06:30

Labopharm announces underwriters' exercise of over-allotment option for recent public offering (CNW Group)

Source: LABOPHARM INC

01:27

Resverlogix Update (CNW Group)

Source: RESVERLOGIX CORP

23:44

Biovail Comments on Filing of Complaints (Business Wire)

TORONTO----Biovail Corporation today acknowledged that separate Complaints have been filed against the Company by S.A.C. Capital Advisors, LLC and Gradient Analytics, Inc. The Complaints, filed in the U.S.

Source: BIOVAIL CORPORATION

23:44

Biovail Comments on Filing of Complaints (Business Wire)

TORONTO----Biovail Corporation today acknowledged that separate Complaints have been filed against the Company by S.A.C. Capital Advisors, LLC and Gradient Analytics, Inc. The Complaints, filed in the U.S.

Source: BIOVAIL CORPORATION

09:21

Notice of Paladin Labs' 2009 Fourth Quarter Results Conference Call (CCNMatthews)

Source: PALADIN LABS INC

09:21

Paladin Labs Announces Amendment to R&D Agreement With Isotechnika Pharma Inc. (CCNMatthews)

Source: PALADIN LABS INC